相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does Food Affect the Pharmacokinetics of Non-orally Delivered Drugs? A Review of Currently Available Evidence
Peng Zou
AAPS JOURNAL (2022)
Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial
Kine Eide Kvitne et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics
Alexia Grangeon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature
Camille Lenoir et al.
FRONTIERS IN PHARMACOLOGY (2021)
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease
Erlend Johannessen Egeland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans
Johannes Matthaei et al.
FRONTIERS IN GENETICS (2020)
Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016
Anitha Saravanakumar et al.
CLINICAL PHARMACOKINETICS (2019)
Food, gastrointestinal pH, and models of oral drug absorption
Ahmad Y. Abuhelwa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach
Guillermo Alberto Keller et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
CYP3A activity: towards dose adaptation to the individual
Nicolas Hohmann et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals
Slobodan Rendic et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers
A. van Rongen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Population Pharmacokinetic Analysis of Circadian Rhythms in Hepatic CYP3A Activity Using Midazolam
Dorota Tomalik-Scharte et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Expression of Hepatic Drug-Metabolizing Cytochrome P450 Enzymes and Their Intercorrelations: A Meta-Analysis
Brahim Achour et al.
DRUG METABOLISM AND DISPOSITION (2014)
Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism
Hylke de Jonge et al.
PHARMACOGENOMICS (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
Michael N. Neely et al.
THERAPEUTIC DRUG MONITORING (2012)
Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?
Chris Kirwan et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Population-Based Mechanistic Prediction of Oral Drug Absorption
Masoud Jamei et al.
AAPS JOURNAL (2009)
Effects of Oral Posaconazole on the Pharmacokinetic Properties of Oral and Intravenous Midazolam: A Phase I, Randomized, Open-Label, Crossover Study in Healthy Volunteers
Gopal Krishna et al.
CLINICAL THERAPEUTICS (2009)
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the cocktail approach
U. Fuhr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
The human intestinal cytochrome P450 pie
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2006)
Comparison of midazolam and simvastatin as cytochromc P450 3A probes
E Chung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Significance of the minor cytochrome P450 3A isoforms
AK Daly
CLINICAL PHARMACOKINETICS (2006)
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states
KS Yu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
分享论文
